Alkermes Inspiration Grants Now Open for Applications
NORTHAMPTON, MA / ACCESSWIRE / May 1, 2023 / The 2023 Alkermes Inspiration Grants® program is now open for applications!…
23,100€
2,21%
Echtzeit-Aktienkurs Alkermes PLC
Bid:
Ask:
Nachrichten zur Alkermes PLC Aktie
Alkermes to Report First Quarter Financial Results on April 26, 2023
DUBLIN, April 19, 2023 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00…
Alkermes: Clinical Trials Integral to Providing More Treatment Options for Platinum-Resistant Ovarian Cancer
NORTHAMPTON, MA / ACCESSWIRE / April 26, 2023 / Patients diagnosed with platinum-resistant Ovarian Cancer (PROC) often face poor prognosis…
Alkermes (ALKS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Alkermes (ALKS) give a sense of how its business performed in the quarter ended…
Alkermes Q1 Adj. Profit Declines; Reiterates 2023 Financial Expectations
WASHINGTON (dpa-AFX) - Alkermes plc (ALKS) reported a first quarter net loss of $41.8 million or a loss per share…
Alkermes plc Q1 Earnings Summary
WASHINGTON (dpa-AFX) - Below are the earnings highlights for Alkermes plc (ALKS):Earnings: -$41.85 million in Q1 vs. -$35.90 million in…
Alkermes plc Reports First Quarter 2023 Financial Results
— First Quarter Revenues of $287.6 Million Reflect Strong Performance of Proprietary Product Portfolio — — GAAP Loss per Share…
Alkermes Q1 2023 Earnings Preview
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Alkermes gets tribunal award in J&J license deal arbitration
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Alkermes Receives Second Interim Award In Janssen Pharmaceutica Arbitration
WASHINGTON (dpa-AFX) - Ireland-headquartered Alkermes plc (ALKS), a fully integrated, global biopharmaceutical company on Tuesday announced that on April 19,…
Alkermes Announces Application Period for 2023 Alkermes Inspiration Grants® Program To Support Innovative Initiatives Focused on People Affected by Addiction, Serious Mental Illness or Cancer
DUBLIN / ACCESSWIRE / April 21, 2023 / Alkermes plc (Nasdaq:ALKS) recently announced that the company will accept applications for…
Alkermes to Report First Quarter Financial Results on April 26, 2023
DUBLIN, April 19, 2023 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00…
Alkermes files SEC document for planned separation of oncology business
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Alkermes Recommits to Equality on Equal Pay Day 2023
NORTHAMPTON, MA / ACCESSWIRE / April 12, 2023 / Alkermes (NASDAQ:ALKS)As part of last months observance of Equal Pay Day…
Alkermes: Dr. Kevin Simon Shares Insights in Implicit Bias and Cultural Stigma
NORTHAMPTON, MA / ACCESSWIRE / March 20, 2023 / Alkermes Last month, Alkermes Mosaic employee resource group hosted a conversation…
Alkermes to Participate in the Stifel 2023 CNS Days
DUBLIN, March 15, 2023 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat…
Alkermes gains amid speculation Sarissa could wage proxy battle after Amarin win
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Alkermes: Supporting Employees Beyond the Workplace - For Our People and for Our Business
NORTHAMPTON, MA / ACCESSWIRE / February 23, 2023 / Alkermes:Originally published by Boston Business Journal on December 22, 2022Its no…
Alkermes (ALKS) Q4 Earnings & Sales Top Estimates, Stock Up
Alkermes (ALKS) earnings and sales beat estimates in the fourth quarter of 2022....…
Form 10-K Alkermes plc. For: Dec 31
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Alkermes (ALKS) Beats Q4 Earnings and Revenue Estimates
Alkermes (ALKS) delivered earnings and revenue surprises of 180% and 6.24%, respectively, for the quarter ended December 2022. Do the…
Alkermes plc Q4 Earnings Summary
WASHINGTON (dpa-AFX) - Below are the earnings highlights for Alkermes plc (ALKS):Earnings: -$28.25 million in Q4 vs. $0.87 million in…
Form 8-K Alkermes plc. For: Feb 16
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Alkermes Q4 2022 Earnings Preview
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Alkermes (ALKS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Alkermes (ALKS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.…
Alkermes: Celebrating Black Mental Health Trailblazers
NORTHAMPTON, MA / ACCESSWIRE / February 7, 2023 / As Black History Month begins, join us in celebrating the accomplishments…
Form 8-K Alkermes plc. For: Feb 03
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Alkermes Celebrates Employee Volunteerism Throughout 2022
NORTHAMPTON, MA / ACCESSWIRE / February 2, 2023 / Alkermes is committed to improving the communities where we live and…
Alkermes: How Is the Brain Affected by Alcohol?
NORTHAMPTON, MA / ACCESSWIRE / January 31, 2023 / AlkermesAs Dry January comes to an end, learn more about how…
Form 8-K Alkermes plc. For: Jan 09
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K Alkermes plc. For: Dec 21
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Alkermes to Present at the 41st Annual J.P. Morgan Healthcare ...
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Alkermes to Present at the 41st Annual J.P. Morgan Healthcare Conference
DUBLIN, Dec. 28, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that its Chief Executive Officer, Richard Pops, will…
Alkermes to Participate in the BofA Securities 2022 Biotech SMID Cap Conference
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Alkermes to Participate in the BofA Securities 2022 Biotech SMID Cap Conference
DUBLIN, Nov. 30, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat…
How Alkermes (ALKS) Stock Stands Out in a Strong Industry
Alkermes (ALKS) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as…
Alkermes to Participate in the 5th Annual Evercore ISI HealthCONx Conference
DUBLIN, Nov. 22, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat…
Alkermes upgraded to overweight at Piper Sandler on oncology business separation
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Alkermes (ALKS) Q3 Earnings Meet Estimates, Revenues Miss
Alkermes (ALKS) earnings meet estimates in the third quarter of 2022 while revenues miss the same. The company tightens total…
Alkermes (ALKS) Q3 Earnings Match Estimates
Alkermes (ALKS) delivered earnings and revenue surprises of 0% and 8.02%, respectively, for the quarter ended September 2022. Do the…
Form 10-Q Alkermes plc. For: Sep 30
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
ROUNDUP: Alkermes Ups Annual Earnings Outlook; To Separate Oncology Business
WASHINGTON (dpa-AFX) - (Adds Outlook; Oncology Business Review)Alkermes plc (ALKS) raised its full-year adjusted earnings outlook to $0.15 - $0.33…
Alkermes plc Q3 Earnings Summary
WASHINGTON (dpa-AFX) - Below are the earnings highlights for Alkermes plc (ALKS):Earnings: -$63.97 million in Q3 vs. -$28.99 million in…
Alkermes plc Reports Third Quarter 2022 Financial Results
— Third Quarter Revenues of $252.4 Million Reflect Strong Year-Over-Year Growth of Proprietary Commercial Product Portfolio — — GAAP Loss…
Form 8-K Alkermes plc. For: Nov 02
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Alkermes Q3 2022 Earnings Preview
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
J&J, Alkermes, AbbVie, others set to benefit from expanding schizophrenia drug market
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K Alkermes plc. For: Oct 13
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Acorda wins $16.5M in Ampyra arbitration case with Alkermes
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Acorda Announces $16.5 Mln Award And Royalty/Supply Relief In AMPYRA Arbitration Case With Alkermes
LONDON (dpa-AFX) - Acorda Therapeutics Inc. (ACOR) said that a three-judge arbitration panel has issued a final decision in a…